Shares of Héroux-Devtek Inc. (TSE:HRX – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$18.38 and traded as high as C$24.41. Héroux-Devtek shares last traded at C$24.00, with a volume of 10,682 shares trading hands.
Analysts Set New Price Targets
Several research firms have recently commented on HRX. TD Securities upped their price target on Héroux-Devtek from C$23.00 to C$28.00 and gave the stock a “buy” rating in a research note on Thursday, May 23rd. Desjardins boosted their price objective on shares of Héroux-Devtek from C$26.00 to C$37.00 and gave the company a “buy” rating in a research note on Thursday, May 23rd. Scotiabank raised their target price on shares of Héroux-Devtek from C$22.50 to C$27.00 and gave the stock an “outperform” rating in a research note on Thursday, May 23rd. Finally, National Bankshares lifted their target price on shares of Héroux-Devtek from C$26.00 to C$29.00 and gave the company an “outperform” rating in a report on Thursday, May 23rd.
Read Our Latest Stock Report on HRX
Héroux-Devtek Stock Performance
Héroux-Devtek (TSE:HRX – Get Free Report) last issued its earnings results on Wednesday, May 22nd. The company reported C$0.49 EPS for the quarter, topping the consensus estimate of C$0.31 by C$0.18. The company had revenue of C$184.05 million for the quarter, compared to analyst estimates of C$170.58 million. Héroux-Devtek had a net margin of 3.97% and a return on equity of 6.05%. Research analysts expect that Héroux-Devtek Inc. will post 1.1295045 EPS for the current fiscal year.
About Héroux-Devtek
Héroux-Devtek Inc engages in the design, development, manufacture, finishing, assembling, and repair and overhaul of aircraft landing gears, hydraulic and electromechanical flight control actuators, custom ball screws, and fracture-critical components. The company serves commercial and defence sectors of the aerospace market.
Featured Articles
- Five stocks we like better than Héroux-Devtek
- What Investors Need to Know About Upcoming IPOs
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- Do ETFs Pay Dividends? What You Need to Know
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- Profitably Trade Stocks at 52-Week Highs
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Receive News & Ratings for Héroux-Devtek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Héroux-Devtek and related companies with MarketBeat.com's FREE daily email newsletter.